Publication Name	World Journal of Clinical Oncology
Manuscript ID	89296
Country	United States

Received	2023-10-28 15:56
Peer-Review Started	2023-10-28 15:59
To Make the First Decision
Return for Revision	2023-12-29 00:47
Revised	2024-01-06 18:57
Second Decision	2024-01-25 03:03
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2024-01-25 05:44
Articles in Press	2024-01-25 05:44
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2024-02-06 08:15
Publish the Manuscript Online	2024-02-20 08:53

ISSN	2218-4333 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Neurosciences
Manuscript Type	Review
Article Title	Updates on management of gliomas in the molecular age
Manuscript Source	Invited Manuscript
All Author List	Ali Ahmed Mohamed, Rakan Alshaibi, Steven Faragalla, Youssef Mohamed and Brandon Lucke-Wold
Funding Agency and Grant Number
Corresponding Author	Brandon Lucke-Wold, MD, PhD, Neurosurgeon, Researcher, Department of Neurosurgery, University of Florida, No. 1505 SW Archer Rd, Gainesville, FL 32611, United States. brandon.lucke-wold@neurosurgery.ufl.edu
Key Words	Gliomas; Chemotherapy; Radiotherapy; Isocitrate dehydrogenase type mutant; Pediatric gliomas; Astrocytoma; Oligodendroglioma; 1p/19q-codeleted
Core Tip	Gliomas are primary brain tumors derived from glial cells of the central nervous system, afflicting both adults and children. This review article explores the therapeutic modalities employed for both adult and pediatric gliomas in the context of their molecular classification. Gliomas are classified by World Health Organization using a grading system grade 1 to 4 differentiating the grades by the gliomas attributes such as progression. The current trident approach to glioma treatment is surgery, radiotherapy, and chemotherapy. Pediatric cases are more nuanced, creating a more challenging approach to treating pediatric gliomas compared to their adult counterpart.
Publish Date	2024-02-20 08:53
Citation	Mohamed AA, Alshaibi R, Faragalla S, Mohamed Y, Lucke-Wold B. Updates on management of gliomas in the molecular age. World J Clin Oncol 2024; 15(2): 178-194
URL	https://www.wjgnet.com/2218-4333/full/v15/i2/178.htm
DOI	https://dx.doi.org/10.5306/wjco.v15.i2.178

Full Article (PDF)	WJCO-15-178-with-cover.pdf
Full Article (Word)	WJCO-15-178.docx
Manuscript File	89296_Auto_Edited-YJP.docx
Answering Reviewers	89296-Answering reviewers.pdf
Audio Core Tip	89296-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	89296-Conflict-of-interest statement.pdf
Copyright License Agreement	89296-Copyright license agreement.pdf
Supplementary Material	89296-Supplementary material.pdf
Peer-review Report	89296-Peer-review(s).pdf
Scientific Editor Work List	89296-Scientific editor work list.pdf
CrossCheck Report	89296-CrossCheck report.pdf